Cargando…
XLF-mediated NHEJ activity in hepatocellular carcinoma therapy resistance
BACKGROUND: DNA repair pathways are used by cancer cells to overcome many standard anticancer treatments, causing therapy resistance. Here, we investigated the role of XRCC4-like factor (XLF), a core member of the non-homologous end joining (NHEJ) repair pathway, in chemoresistance in hepatocellular...
Autores principales: | Yang, Sitian, Wang, Xiao Qi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5437682/ https://www.ncbi.nlm.nih.gov/pubmed/28526069 http://dx.doi.org/10.1186/s12885-017-3345-y |
Ejemplares similares
-
PAXX binding to the NHEJ machinery explains functional redundancy with XLF
por: Seif-El-Dahan, Murielle, et al.
Publicado: (2023) -
C-NHEJ without indels is robust and requires synergistic function of distinct XLF domains
por: Bhargava, Ragini, et al.
Publicado: (2018) -
Erratum for the Research Article: “PAXX binding to the NHEJ machinery explains functional redundancy with XLF”
Publicado: (2023) -
Cdk1 Restrains NHEJ through Phosphorylation of XRCC4-like Factor Xlf1
por: Hentges, Pierre, et al.
Publicado: (2014) -
Structural and functional basis of inositol hexaphosphate stimulation of NHEJ through stabilization of Ku-XLF interaction
por: Kefala Stavridi, Antonia, et al.
Publicado: (2023)